Pleural LDH as a prognostic marker in adenocarcinoma lung with malignant pleural effusion

To study the performance of serum and pleural lactate dehydrogenase (LDH) level in predicting survival in patients with adenocarcinoma lung presenting with malignant pleural effusions (MPE) at initial diagnosis. Retrospective cohort study of the patient hospitalized for adenocarcinoma lung with MPE...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Akash, Phua, Chee Kiang, Sim, Wen Yuan, Algoso, Reyes Elmer, Tee, Kuan Sen, Lew, Sennen J. W., Lim, Albert Y. H., Goh, Soon Keng, Tai, Dessmon Y. H., Kor, Ai Ching, Ho, Benjamin, Abisheganaden, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937920/
https://www.ncbi.nlm.nih.gov/pubmed/27368006
http://dx.doi.org/10.1097/MD.0000000000003996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937920/
https://www.ncbi.nlm.nih.gov/pubmed/27368006
http://dx.doi.org/10.1097/MD.0000000000003996

Ejemplares similares